Supplementary Data from Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Authors :: Feyruz V. Rassool
Stephen B. Baylin
Benjamin A. Youngblood
Casey L. O'Connell
Sandrine Niyongere
Ashkan Emadi
Vu H. Duong
Rena G. Lapidus
Tian Mi
Søren M. Bentzen
Aksinija A. Kogan
Maria R. Baer
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Data from Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Full Text Access

Tools